Family · Pharmaceutical analytical standards
Olodaterol
A long-acting beta-2 agonist bronchodilator, developed in Germany and approved in 2013 in Europe and in 2014 in the United States for maintenance treatment of chronic obstructive pulmonary disease (COPD). This family brings together the active ingredient and other impurities.
Did you know?It is delivered by a pocket-sized inhaler that, using only mechanical energy, turns the solution into a soft, slow-moving mist.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
